H15.053
Scleromalacia perforans, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Scleromalacia perforans is a rare eye condition characterized by thinning of the sclera, the white outer layer of the eye. When it affects both eyes simultaneously, it is termed bilateral scleromalacia perforans. This condition is often associated with systemic autoimmune diseases, particularly rheumatoid arthritis. Recognizing the signs and understanding its implications can help in timely management, though treatment strategies are typically guided by medical professionals.
Causes & Symptoms
Clinical Causes: Autoimmune diseases, especially rheumatoid arthritis Inflammatory disorders affecting connective tissue Previous eye trauma or injury Certain infections leading to scleral weakening Age-related degenerative changes
Key Symptoms: Gradual or sudden loss of vision Visible bluish or grayish sclera due to thinning Localized redness or inflammation Tissue necrosis or perforation in advanced cases Discomfort or aching in the affected eye(s)
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive eye examination, including slit-lamp biomicroscopy to assess scleral thinning and perforations. Medical history review for underlying autoimmune disorders is essential. Additional tests may include imaging studies like ultrasound or MRI to evaluate the extent of tissue damage. Blood tests may be conducted to identify associated systemic conditions, such as rheumatoid factors. Regular monitoring is crucial to track disease progression.
Treatment Protocols: Treatment options focus on halting disease progression and preserving vision. Approaches include:
Clinical Advice & FAQs
Billing Guidance
Is H15.053 a billable ICD-10 code?
Yes, H15.053 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H15.053?
Clinical documentation must specify the nature of Scleromalacia perforans, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference